Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $3.0 million.

  • Utah Medical Products' Operating Expenses rose 2171.61% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year decrease of 1409.72%. This contributed to the annual value of $8.6 million for FY2024, which is 2529.37% down from last year.
  • As of Q3 2025, Utah Medical Products' Operating Expenses stood at $3.0 million, which was up 2171.61% from $2.4 million recorded in Q2 2025.
  • Utah Medical Products' 5-year Operating Expenses high stood at $3.4 million for Q1 2023, and its period low was $492000.0 during Q4 2024.
  • For the 5-year period, Utah Medical Products' Operating Expenses averaged around $2.6 million, with its median value being $3.0 million (2021).
  • Its Operating Expenses has fluctuated over the past 5 years, first plummeted by 6650.78% in 2024, then surged by 2171.61% in 2025.
  • Quarter analysis of 5 years shows Utah Medical Products' Operating Expenses stood at $1.6 million in 2021, then rose by 11.54% to $1.8 million in 2022, then fell by 16.06% to $1.5 million in 2023, then crashed by 66.51% to $492000.0 in 2024, then surged by 508.33% to $3.0 million in 2025.
  • Its Operating Expenses was $3.0 million in Q3 2025, compared to $2.4 million in Q2 2025 and $2.4 million in Q1 2025.